Innovation

Transplant Transmitted Infections

Ensuring the gift of life is safely delivered

For certain health conditions, transplantation of solid organs, tissues, or cells from a donor to a recipient is often the only cure.

End-stage organ failure is estimated to affect more than six million people worldwide.1 Advancements in surgical techniques, immunosuppression, donor–recipient matching, and antimicrobial agents have all contributed to increase patient success during transplant procedures.2 

However, complications due to infection after transplantation are one of the main causes of post-operative morbidity and mortality— including rejection or loss of the graft or the transplant, among other challenges.3

Clinical laboratorians play a key role in the success of transplant programs

Minimizing risk requires comprehensive and reliable pre- and post-transplant testing.

From initial screening to post-transplantation follow-up, several samples are needed to run multiple tests for possible pathogens. Across serologic and molecular testing, increased automation, broad testing menus, and streamlined workflows are enabling laboratories to more efficiently process samples and identify potentially problematic pathogens. 

Two female lab technicians working in a lab
Providing end-to-end coverage from the inside out

Roche’s robust portfolio of transplant screening, infection monitoring, and therapeutic drug monitoring assays is designed to support you in giving patients the best chance at a second chance. 

Across the diagnostic continuum of transplant donors and recipients, Roche offers a comprehensive range of serological and molecular tests that cover 80% of the most common infections.

  • Highly specific and sensitive assays minimize unnecessary discarding of transplants and ensure safe transplantations
  • Traceability of viral load results allows for convenient patient follow-up


To optimize infection management, Roche’s fully automated systems can run multiple tests from a single sample, delivering trusted results quickly.

  • Fully automated workflows reduce the potential for human error
  • Standardized processes ensure predictable turnaround times
  • Reproducible results allow for confident decision-making
Close up of assays in a laboratory instrument
Committed to protecting patients and the gift of life with continuous innovation

Protecting patients means making the most of every donation. With a robust portfolio of reliable testing solutions, to ensure that the gift of life is safely delivered.

Lab technician

Molecular diagnostics

See how our unique solutions are pushing the boundaries of  traditional diagnostics to address the real-world needs of laboratories, their customers, and the patients they serve.

Learn more
Lab technician standing near cobas 8000 analyzer

Immunosuppressive Drug Assay Panel

Explore our solution for precise and consistent measurement of immunosuppressive drugs (ISDs).

Explore our portfolio of transplant testing solutions

ADV NAT testing

In vitro nucleic acid amplification test for the detection and quantification of human Adenovirus (ADV) DNA in human EDTA plasma.

Learn more

BKV NAT testing

In vitro nucleic acid amplification test for the quantification of BK virus (BKV) DNA in human EDTA plasma.

Learn more

CMV NAT testing

In vitro nucleic acid amplification test for the quantitation of Cytomegalovirus virus (CMV) DNA in human EDTA plasma.

Learn more

EBV NAT testing

An in vitro nucleic acid amplification test for the quantification of Epstein-Barr virus (EBV) DNA in human EDTA plasma.

Learn more

HSV/VZV NAT testing

In vitro nucleic acid amplification test for the qualitative detection of human Herpes Simplex Virus-1 (HSV-1), Herpes Simplex Virus-2 (HSV-2) and Varicella Zoster Virus (VZV) DNA in human EDTA plasma.

Learn more

CMV antibody test

Complete panel of immunoassays for the determination of IgM and IgG antibodies against CMV, including IgG avidity

Learn more

EBV antibody testing panel

Immunoassay panel for the qualitative determination of antibodies against EBV. 

Learn more

ECLIA dual antigen and antibody HIV test

Immunoassay for the qualitative determination of HIV p24 antigen and antibodies to HIV.

Learn more

HBsAg antigen test

Immunoassay for the qualitative determination of hepatitis B surface antigen (HBsAg).

Learn more

HSV-1 antibody test

Immunoassay for the qualitative determination of IgG-antibodies to Herpes Simplex Virus type 1.

Learn more

HSV-2 antibody test

Immunoassay for the qualitative determination of IgG-antibodies to Herpes Simplex Virus type 2.

Learn more

Human T-lymphotropic virus I/II antibody test

Immunoassay for the qualitative determination of total antibodies to human T-lymphotropic virus I/II (HTVL-I/II).

Learn more

Trypanosoma cruzi antibody test

Immunoassay for the determination of antibodies to Trypanosoma cruzi.

Learn more

References

  1. Levin A, Tonelli M, Bonventre J, et al. Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy. Lancet. 2017;390(10105):1888-1917. doi:10.1016/S0140-6736(17)30788-2.
  2. Rana A, Godfrey EL. Outcomes in Solid-Organ Transplantation: Success and Stagnation. Tex Heart Inst J. 2019;46(1):75-76.
  3. Jha V. Post-transplant infections: An ounce of prevention. Indian J Nephrol. 2010;20(4):171-178.
  4. Rao YG, Mirza DF. Infections transmitted from donors to recipients following organ transplantation. Natl Med J India. 2005;18(4):189-194.
  5. Kumar R, Ison MG. Opportunistic Infections in Transplant Patients. Infect Dis Clin North Am. 2019;33(4):1143-1157.
  6. Almaghrabi RS, Omrani AS, Memish ZA. Cytomegalovirus infection in lung transplant recipients. Expert Rev Respir Med. 2017;11(5):377-383.
  7. Vanichanan J, Udomkarnjananun S, Avihingsanon Y, Jutivorakool K. Common viral infections in kidney transplant recipients. Kidney Res Clin Pract. 2018;37(4):323-337.
  8. Robert-Gangneux F, Meroni V, Dupont D, et al. Toxoplasmosis in Transplant Recipients, Europe, 2010-2014. Emerg Infect Dis. 2018;24(8):1497-1504.
  9. Ahn C, Amer H, Anglicheau D, et al. Global Transplantation COVID Report March 2020. Transplantation. 2020;10.1097.
  10. The American Association for Clinical Chemistry. The Laboratory’s Role in Solid Organ Transplantation.
    https://www.aacc.org/publications/cln/articles/2016/november/the-laboratorys-role-in-solid-organ-transplantation. Accessed September 17, 2020.
  11. Razonable RR, Paya CV, Smith TF. Role of the laboratory in diagnosis and management of cytomegalovirus infection in hematopoietic stem cell and solid-organ transplant recipients.